Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Learn which cryptocurrencies show the lowest volatility and how that can stabilize a portfolio. This intro covers metrics, risk factors, and practical steps.
27,498 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Bitcoin fell below $73,000 in a sharp session, rekindling fears of a broader risk-off move. Analysts point to macro p...
Cardano is at a pivotal juncture as social chatter and on-chain activity surge while ADA trades near multi-year lows,...
Oil prices tumbled after President Trump signaled that an Iran deal would be signed this Friday, triggering a broad s...
A tech-focused ETF concentrates 32.8% of its holdings in four giants. Learn what this means for potential gains, risk...
NVDY investors are prioritizing regular income over Nvidia-driven gains, a trade that has weighed on NAV and long-ter...
Accelerant Holdings has fallen sharply since its IPO, but a major fund just took a sizable stake. This article explai...
Aptos has seen a notable price drop even with multiple upbeat developments. This deep dive explains what’s driving th...
Greg Abel is redefining Berkshire Hathaway’s course with three bold moves: pruning a laggard investment, expanding ho...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
Oil markets bounce as Strait of Hormuz risks flare and Beijing delays a high-stakes summit. The United States undermi...
As housing markets shift, investors wonder if Opendoor can deliver a meaningful stock reaction by 2026. This guide br...